Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,619 across all filing types
Latest filing 2014-04-25 Major Shareholding Noti…
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
103年04月僑外投資持股
Major Shareholding Notification Classification · 95% confidence The document is a statistical table showing the shareholding situation of overseas and mainland China investors, with specific dates and share counts. It includes details about shareholding changes related to a shareholders' meeting (股東會) but does not contain financial statements, management discussion, or detailed report content. The document length is short (1049 characters) and it mainly reports shareholding data changes around a shareholders' meeting. This fits best with a Major Shareholding Notification (MRQ) as it reports changes in significant share ownership levels, especially related to foreign investors and shareholders' meeting events. It is not an announcement of a report publication, nor a full financial report or management report. Therefore, the classification is MRQ with high confidence.
2014-04-25 Chinese
103年03月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on personal share transactions and holdings by company insiders rather than financial results, management commentary, or regulatory announcements. There is no indication of a full financial report, earnings release, or meeting materials. The document is a report of personal share transactions by company directors and executives, fitting the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data on insider shareholdings and changes, confirming it is not a mere announcement or certification.
2014-04-10 Chinese
103年03月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and executives. It provides specific data on share counts, pledged shares, and related ratios. The content focuses on insider shareholdings and pledging status rather than financial results, management changes, or meeting materials. This type of disclosure aligns with reporting of personal share transactions or holdings by company directors and executives. Given the nature of the data and the focus on insider holdings, the document fits best under the category of Director's Dealing (DIRS). The document length is 2485 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report.
2014-04-10 Chinese
103年3月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 景岳, with data presented for March 2014 (民國103年03月). It includes percentage changes compared to the previous year and explanatory notes about accounting standards and reporting practices. The document is very short (766 characters) and does not contain detailed financial statements or comprehensive analysis. It appears to be a regulatory disclosure or a brief financial summary rather than a full financial report. There is no indication that this is an earnings release, annual report, or interim report. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2014-04-10 Chinese
103年3月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 景岳, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements, no management discussion, no earnings highlights, no meeting materials, and no legal or regulatory narrative. The document is very short (601 characters) and appears to be a routine regulatory disclosure of financial guarantees and loans status. This type of document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2014-04-10 Chinese
公告本公司申請股票上櫃轉上市時所出具之承諾事項 暨其後續執行情形
Regulatory Filings Classification · 95% confidence The document is a public announcement from a listed company (3164 景岳) regarding commitments made when applying for stock listing transfer and the subsequent execution status. It references compliance with Taiwan Stock Exchange regulations and details specific commitments and their current status as of a certain date. The document is short (1004 characters) and primarily provides regulatory compliance information rather than financial data or detailed reports. It does not contain financial statements or detailed management discussion. This fits the category of a Regulatory Filing (RNS), as it is a compliance announcement that does not fit other specific categories like Annual Report or Interim Report.
2014-04-02 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.